{"id":24202,"date":"2014-06-02T09:12:01","date_gmt":"2014-06-02T13:12:01","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=24202"},"modified":"2014-06-02T09:12:01","modified_gmt":"2014-06-02T13:12:01","slug":"valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202","title":{"rendered":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 06\/02\/2014 (wallstreetpr) \u2013<b> Valeant Pharmaceuticals Intl Inc (NYSE:VRX)<\/b> increased its offer to acquire <b>Allergan, Inc. (NYSE:AGN) <\/b>for the second time in the week.<\/p>\n<p style=\"text-align: justify;\"><b>Second Raise In A Week<\/b><\/p>\n<p style=\"text-align: justify;\">The Canada based drug maker said on Friday that it is agreeable to offer $72 and in addition a part of its stock for each of Allergan\u2019s share. Prior to this, the company had made an offer of $58.30 on Wednesday for the Botox maker. It has increased the cash portion of the offer to earn the support of the company\u2019s executive and investors. Valeant Pharmaceuticals Intl Inc (NYSE:VRX)\u2019s latest offer amounts to as much as $53 billion, as per the closing price of its shares on Thursday. The company, however, said that the offer relies on the opposite party\u2019s immediate and good faith deal of a merger agreement.<\/p>\n<p style=\"text-align: justify;\">The Irvine, California based company had rejected the offer Valeant Pharmaceuticals Intl Inc (NYSE:VRX) had proposed earlier this month. The $46 billion offer, it had claimed, was undervaluing the company. This had pushed Valeant to reconsider and it then came up with a bid of $25 per share. This was a conditional value based on the future sales of Allergan\u2019s proposed eye treatment.<\/p>\n<p style=\"text-align: justify;\"><b>Ackman Seeks More For Other Shareholders<\/b><\/p>\n<p style=\"text-align: justify;\">The second surge in the Laval, Quebec based company\u2019s offer now allows Allergan holders $72 per share in cash. As part of the offer, Allergan\u2019s largest shareholder, Pershing Square Capital Management, agreed to let go off the cash part of the bid so as to push other investors to agree. Its chief executive, Bill Ackman, said that this would mean a discount to other shareholders of around $20.75 per share. On May 29, he had said that he is willing to let go off the hedge fund\u2019s gain if Valeant\u2019s CEO, Mike Pearson, agrees to raise the offer for other shareholders.<\/p>\n<p style=\"text-align: justify;\">Allergan, Inc. (NYSE:AGN) said in a statement and said that its board of directors will be considering the new offer. It bid its shareholders to refrain from taking action yet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 06\/02\/2014 (wallstreetpr) \u2013 Valeant Pharmaceuticals Intl Inc (NYSE:VRX) increased its offer to acquire Allergan, Inc. (NYSE:AGN) for the second time in the week. [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":24206,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[6993,6035,6036,2046,3036,2045],"stock_ticker":[],"class_list":["post-24202","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-allergan-inc","tag-allergan-inc-nyseagn","tag-nyseagn","tag-nysevrx","tag-valeant-pharmaceuticals-intl-inc","tag-valeant-pharmaceuticals-intl-inc-nysevrx","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 06\/02\/2014 (wallstreetpr) \u2013 Valeant Pharmaceuticals Intl Inc (NYSE:VRX) increased its offer to acquire Allergan, Inc. (NYSE:AGN) for the second time in the week. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-02T13:12:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"280\" \/>\n\t<meta property=\"og:image:height\" content=\"180\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Van Bettauer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Van Bettauer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202\"},\"author\":{\"name\":\"Van Bettauer\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\"},\"headline\":\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN)\",\"datePublished\":\"2014-06-02T13:12:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202\"},\"wordCount\":359,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg\",\"keywords\":[\"Allergan Inc.\",\"Allergan Inc. (NYSE:AGN)\",\"NYSE:AGN\",\"NYSE:VRX\",\"Valeant Pharmaceuticals Intl Inc\",\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202\",\"name\":\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg\",\"datePublished\":\"2014-06-02T13:12:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg\",\"width\":280,\"height\":180},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d\",\"name\":\"Van Bettauer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g\",\"caption\":\"Van Bettauer\"},\"description\":\"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202","og_locale":"en_US","og_type":"article","og_title":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN) - Wall Street PR","og_description":"Boston, MA 06\/02\/2014 (wallstreetpr) \u2013 Valeant Pharmaceuticals Intl Inc (NYSE:VRX) increased its offer to acquire Allergan, Inc. (NYSE:AGN) for the second time in the week. [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-06-02T13:12:01+00:00","og_image":[{"width":280,"height":180,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg","type":"image\/jpeg"}],"author":"Van Bettauer","twitter_misc":{"Written by":"Van Bettauer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202"},"author":{"name":"Van Bettauer","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d"},"headline":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN)","datePublished":"2014-06-02T13:12:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202"},"wordCount":359,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg","keywords":["Allergan Inc.","Allergan Inc. (NYSE:AGN)","NYSE:AGN","NYSE:VRX","Valeant Pharmaceuticals Intl Inc","Valeant Pharmaceuticals Intl Inc (NYSE:VRX)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202","url":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202","name":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg","datePublished":"2014-06-02T13:12:01+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/val.jpg","width":280,"height":180},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/valeant-pharmaceuticals-intl-inc-nysevrx-raises-bid-to-53-billion-to-buy-allergan-inc-nyseagn-24202#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/086385e1495fa1df08b6dabd5d8a4e5d","name":"Van Bettauer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/96de7d8946529978255828dc0fee029f894f4355641bdd9b5d409917697f57b1?s=96&d=mm&r=g","caption":"Van Bettauer"},"description":"Van Bettauer is a financial aficionado from Vancouver, British Columbia. He currently studies at UBC, pursuing a Bachelors of Science degree. Van has been freelance writing for many years, specializing in copywriting, report writing and article writing. The combination of his scientific studies and writing experience brings a new and fresh perspective to the financial world. Visit Bettauer's Google+ page at the following address: https:\/\/plus.google.com\/100770875710593766367\/posts","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/van-bettauer"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/24202","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=24202"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/24202\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/24206"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=24202"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=24202"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=24202"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=24202"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}